We are live on ! Find out more
KIA

KCM Investment Advisors Portfolio holdings

AUM $3.01B
1-Year Est. Return 21.97%
This Fund
S&P 500
This Quarter Est. Return
+6.73%
1 Year Est. Return
+21.97%
3 Year Est. Return
+71.25%
5 Year Est. Return
+89.24%
10 Year Est. Return
+291.31%
AUM
$2.95B
AUM Growth
+$166M
Cap. Flow
-$2.28M
Cap. Flow %
-0.08%
Top 10 Hldgs %
32.38%
Holding
380
New
13
Increased
129
Reduced
159
Closed
7

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.92M
2
COST icon
Costco
COST
+$2.23M
3
BLK icon
Blackrock
BLK
+$1.88M
4
JNJ icon
Johnson & Johnson
JNJ
+$1.57M
5
USB icon
US Bancorp
USB
+$1.13M

Sector Composition

Rank Sector Weight
1 Technology 18.9%
2 Consumer Staples 8.27%
3 Healthcare 7.57%
4 Consumer Discretionary 7.17%
5 Industrials 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
126
Goldman Sachs
GS
$303B
$3.17M 0.11%
6,406
+37
+0.6% +$18.1K
LMT icon
127
Lockheed Martin
LMT
$136B
$3.16M 0.11%
5,402
+120
+2% +$64.4K
FTNT icon
128
Fortinet
FTNT
$117B
$3.15M 0.11%
40,630
-2,440
-6% -$167K
FCX icon
129
Freeport-McMoran
FCX
$97.5B
$3.08M 0.1%
61,768
-202
-0.3% -$9.1K
XLG icon
130
Invesco S&P 500 Top 50 ETF
XLG
$11B
$3.06M 0.1%
64,356
SO icon
131
Southern Company
SO
$107B
$3.04M 0.1%
33,738
-8
-0% -$683
PPL
132
PPL Corp
PPL
$26.7B
$3.03M 0.1%
91,486
+3,631
+4% +$111K
PLD icon
133
Prologis
PLD
$133B
$3.01M 0.1%
23,842
-74
-0.3% -$9.18K
FNY icon
134
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$604M
$3M 0.1%
37,693
-1,005
-3% -$76.1K
IBB icon
135
iShares Biotechnology ETF
IBB
$9.77B
$2.97M 0.1%
20,381
-469
-2% -$67.9K
MKC icon
136
McCormick & Company Non-Voting
MKC
$14.2B
$2.91M 0.1%
35,333
-124
-0.3% -$9.66K
BAC.PRL icon
137
Bank of America Series L
BAC.PRL
$3.99B
$2.86M 0.1%
2,249
+37
+2% +$45.5K
VRT icon
138
Vertiv
VRT
$105B
$2.86M 0.1%
28,730
+4,595
+19% +$381K
ROP icon
139
Roper Technologies
ROP
$39.8B
$2.83M 0.1%
5,085
+1,098
+28% +$604K
CORT icon
140
Corcept Therapeutics
CORT
$12B
$2.66M 0.09%
57,426
MS icon
141
Morgan Stanley
MS
$340B
$2.66M 0.09%
25,478
-338
-1% -$34K
IRM icon
142
Iron Mountain
IRM
$36.1B
$2.56M 0.09%
21,558
-600
-3% -$64.2K
ITW icon
143
Illinois Tool Works
ITW
$84.5B
$2.55M 0.09%
9,729
+18
+0.2% +$4.43K
DGRO icon
144
iShares Core Dividend Growth ETF
DGRO
$43.5B
$2.54M 0.09%
40,438
-2,543
-6% -$153K
LULU icon
145
lululemon athletica
LULU
$14.6B
$2.5M 0.08%
9,220
+375
+4% +$99.5K
IAT icon
146
iShares US Regional Banks ETF
IAT
$681M
$2.46M 0.08%
51,762
+2,113
+4% +$97.3K
IJH icon
147
iShares Core S&P Mid-Cap ETF
IJH
$127B
$2.45M 0.08%
39,258
-867
-2% -$52.3K
SRE icon
148
Sempra
SRE
$54.8B
$2.44M 0.08%
29,166
-1,550
-5% -$124K
OMC icon
149
Omnicom Group
OMC
$23.4B
$2.42M 0.08%
23,403
+2,737
+13% +$263K
WFC icon
150
Wells Fargo
WFC
$264B
$2.26M 0.08%
39,996
-744
-2% -$42.1K

Similar funds

KCM Investment Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, KCM Investment Advisors held 380 positions worth $2.95B, up 6% from $2.79B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

KCM Investment Advisors's Q3 2024 filing shows 13 new, 129 increased, 159 reduced and 7 closed positions. Its largest new stake was Labcorp: 32,995 shares worth $7.37M. The largest sale was Apple, an estimated $2.92M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Staples and Healthcare.

  • KCM Investment Advisors's largest Q3 2024 buy was Labcorp: 32,995 shares worth $7.37M.
  • KCM Investment Advisors added most to L3Harris in Q3 2024, an estimated $1.35M increase.
  • KCM Investment Advisors's biggest Q3 2024 reduction was Apple, cutting an estimated $2.92M.
  • KCM Investment Advisors fully exited Blackrock in Q3 2024, selling an estimated $1.88M.
  • KCM Investment Advisors's ten largest holdings make up 32% of its $2.95B portfolio in Q3 2024.
  • KCM Investment Advisors opened 13 new positions and closed 7 in Q3 2024.
  • KCM Investment Advisors's portfolio value rose 6% quarter-over-quarter to $2.95B.

Based on KCM Investment Advisors's 13F filing for Q3 2024, filed 6 Nov 2024.